Former Google Executive to Lead Cancer Diagnostics Firm

Advertisement
By Reuters | Updated: 10 February 2016 17:38 IST
Grail, a healthcare firm developing a blood test for early cancer detection, named former Google X Senior Vice President Jeff Huber as its CEO Wednesday.

Huber said he wants to apply his experience building large-scale data systems to improve the gene sequencing technology used by Grail to detect cancerous material in patients who show no symptoms of the disease.

San Francisco-based Grail was formed by gene sequencing company Illumina Inc and received more than $100 million (roughly Rs. 678 crores) in Series A financing. Illumina is the majority owner. Key investors include technology giants Bill Gates, founder of Microsoft, and Jeff Bezos, founder of Amazon.com, as well as ARCH Venture Partners and Sutter Hill Ventures.

"Jeff helped Google map the world, and he'll help us map the molecular biology of the microscopic cancer DNA that might be circulating in our blood," said Grail board chair and Illumina CEO Jay Flatley.

Advertisement

Huber had more than a decade of experience building the systems that manage and analyze the data used for AdWords, Google Maps and the Google Apps suite before he joined Google X in 2013. It was at the research facility, known for developing self-driving cars and delivery drones, that Huber kicked off his next professional adventure of pairing data and life sciences.

Advertisement

The work took a deeply personal turn for Huber a few months after the change at Google when his wife, Laura, was diagnosed with Stage IV colon cancer. She died of the disease in November after what he called an "incredibly brave 18-month battle."

"I had already been ramping up on the biology and science behind this and then there was this very poignant reminder of the implications that there has to be a better way to do this," said Huber.

Advertisement

For the next three years, Huber said Grail's goal is to see the technology behind cancer detection and location improved and to begin large-scale clinical trials of its cancer-detection system.

The initial target market for testing will be individuals with a genetic predisposition to cancer, once it's cleared for widespread use. The ultimate goal is to see it used as "part of annual physical exams," Huber said.

Advertisement

© Thomson Reuters 2016

 

For the latest tech news and reviews, follow Gadgets 360 on X, Facebook, WhatsApp, Threads and Google News. For the latest videos on gadgets and tech, subscribe to our YouTube channel. If you want to know everything about top influencers, follow our in-house Who'sThat360 on Instagram and YouTube.

Advertisement

Related Stories

Popular Mobile Brands
  1. Amazon Great Indian Festival Sale: Deals on Smartphones, Laptops Teased
  2. iQOO 15 Tipped to Debut With 7,000mAh Battery and This Snapdragon Chip
  3. Your Gmail Password Might Have Been Leaked: How to Secure Your Account
  4. Realme 15T With 50-Megapixel Selfie Camera Debuts in India: See Price
  5. Realme 15T 5G India Launch Today: All You Need to Know
  1. BCCI Says Crypto, Real Money Gaming Platforms Can’t Bid for Team India’s Title Sponsorship
  2. Scientists Discover Hidden Mantle Layer Beneath the Himalayas Challenging Century-Old Theory
  3. Astronomers Propose Rectangular Telescope to Hunt Earth-Like Planets
  4. Microsoft Testing Native Clipboard Sync Feature to Share Text Between Windows PCs, Android Devices
  5. Su From So OTT Release: When and Where to Watch This Kannada-Language Horror-Comedy Online
  6. Sennheiser Momentum 4 Wireless 80th Anniversary Edition Launched in India With Up to 60 Hour Battery Life
  7. Call of Duty Film Adaption Said to Be a 'Priority' at Paramount, Negotiations on to Acquire Rights
  8. Cannibal Solar Storm May Trigger Auroras as Powerful Geomagnetic Storm to Hit Earth Soon
  9. Apple's iPhone 8 Plus Listed as Vintage Product Ahead of iPhone 17 Launch, 11-Inch MacBook Air Now Obsolete
  10. Hidden Reason Behind Portugal’s Deadly Earthquakes Finally Explained
Gadgets 360 is available in
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2025. All rights reserved.